Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colon Cancer
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01918527
- Collaborators
- Not Provided
- Investigators
- Study Chair: Anders Jakobsen, DMSc Vejle Hospital, Vejle, Denmark Principal Investigator: Henrik Jensen, MD, PhD Vejle Hospital, Vejle, Denmark Principal Investigator: Olav Dahl, MD Haukeland University Hospital, Bergen, Norway Principal Investigator: Göran Carlsson, MD Sahlgrenska University Hospital, Gothenburg, Sweden